Oncostatin M production by blood and alveolar neutrophils during acute lung injury.
Polymorphonuclear neutrophils (PMN) are involved in the pathogenesis of acute lung injury (ALI), secreting numerous mediators such as proteases, reactive oxygen species, and cytokines. Because we had recently observed the ability of normal human PMN to degranulate and synthesize oncostatin M (OSM), an IL-6-family cytokine, we quantified OSM production ex vivo by highly purified blood and alveolar PMN from 24 ventilated patients with ALI, including some patients with severe pneumonia. Most of the patients had no detectable OSM in plasma, and OSM production by cultured blood PMN was similar to that of healthy controls. However, OSM was present in bronchoalveolar lavage (BAL) fluid supernatant, with significantly higher levels during pneumonia. In addition, alveolar OSM levels correlated with the number of PMN obtained by BAL, suggesting that PMN are an important source of OSM within the alveoli. Indeed, purified alveolar PMN from all of the patients, especially those with pneumonia, strongly produced OSM. Interestingly, in the latter patients, alveolar PMN always produced more OSM than autologous blood PMN. These results document the functional duality of PMN in ALI by showing the participation of PMN in the modulation of lung inflammation.
Service de Biochimie, CHI Le Raincy-Montfermeil, France.
A
A
Grenier
D
D
Combaux
J
J
Chastre
M A
MA
Gougerot-Pocidalo
C
C
Gibert
M
M
Dehoux
S
S
Chollet-Martin
D000368:Aged; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology / Q000276:immunology; D017714:Community-Acquired Infections / Q000503:physiopathology; D016207:Cytokines / Q000096:biosynthesis / Q000097:blood; D006333:Heart Failure / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D007150:Immunohistochemistry; D008168:Lung / Q000503:physiopathology*; D055370:Lung Injury; D008875:Middle Aged; D009504:Neutrophils / Q000502:physiology*; D053683:Oncostatin M; D010455:Peptides / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D011014:Pneumonia / Q000503:physiopathology* / Q000628:therapy; D011183:Postoperative Complications; D011650:Pulmonary Alveoli / Q000503:physiopathology*; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000503:physiopathology* / Q000628:therapy
D016207:Cytokines; C508351:OSM protein, human; D010455:Peptides; D053683:Oncostatin M